Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Plaque, Atherosclerotic | 88 | 2024 | 1519 | 6.380 |
Why?
|
Tomography, Optical Coherence | 97 | 2024 | 2657 | 3.840 |
Why?
|
Acute Coronary Syndrome | 57 | 2024 | 2337 | 3.370 |
Why?
|
Coronary Vessels | 73 | 2024 | 3107 | 3.300 |
Why?
|
Coronary Artery Disease | 71 | 2024 | 6486 | 2.800 |
Why?
|
Teriparatide | 20 | 2022 | 225 | 2.340 |
Why?
|
Bone Density | 54 | 2023 | 3468 | 2.110 |
Why?
|
Osteoporosis, Postmenopausal | 13 | 2023 | 386 | 1.790 |
Why?
|
Bone Density Conservation Agents | 20 | 2023 | 772 | 1.750 |
Why?
|
Coronary Angiography | 73 | 2024 | 4576 | 1.600 |
Why?
|
Coronary Thrombosis | 10 | 2021 | 495 | 1.080 |
Why?
|
Ultrasonography, Interventional | 19 | 2023 | 1486 | 0.970 |
Why?
|
Amenorrhea | 10 | 2018 | 485 | 0.950 |
Why?
|
Students | 13 | 2009 | 1647 | 0.800 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 15 | 2020 | 3255 | 0.760 |
Why?
|
Testosterone | 17 | 2020 | 2419 | 0.730 |
Why?
|
Bone and Bones | 14 | 2023 | 2576 | 0.720 |
Why?
|
Universities | 9 | 2009 | 951 | 0.700 |
Why?
|
Athletes | 11 | 2019 | 1093 | 0.690 |
Why?
|
Middle Aged | 235 | 2024 | 213390 | 0.670 |
Why?
|
Body Composition | 21 | 2023 | 2402 | 0.660 |
Why?
|
Female | 296 | 2024 | 380193 | 0.650 |
Why?
|
Humans | 387 | 2024 | 744366 | 0.590 |
Why?
|
Gonadotropin-Releasing Hormone | 11 | 2021 | 1206 | 0.580 |
Why?
|
Drug-Eluting Stents | 8 | 2017 | 753 | 0.570 |
Why?
|
Lipids | 19 | 2023 | 3307 | 0.550 |
Why?
|
Male | 238 | 2024 | 350115 | 0.540 |
Why?
|
Myocardial Infarction | 18 | 2024 | 11718 | 0.540 |
Why?
|
Growth Hormone-Releasing Hormone | 4 | 2021 | 213 | 0.540 |
Why?
|
Predictive Value of Tests | 47 | 2023 | 15078 | 0.540 |
Why?
|
Ovarian Neoplasms | 21 | 2020 | 4839 | 0.540 |
Why?
|
Alcohol Drinking | 10 | 2009 | 3966 | 0.530 |
Why?
|
Atherosclerosis | 12 | 2024 | 3444 | 0.530 |
Why?
|
Bone Remodeling | 11 | 2019 | 575 | 0.530 |
Why?
|
Alendronate | 7 | 2023 | 171 | 0.530 |
Why?
|
Anorexia Nervosa | 8 | 2018 | 1286 | 0.520 |
Why?
|
Coronary Stenosis | 7 | 2021 | 834 | 0.520 |
Why?
|
HIV Infections | 26 | 2024 | 16715 | 0.510 |
Why?
|
Aged | 151 | 2024 | 163288 | 0.500 |
Why?
|
Chest Pain | 8 | 2015 | 1114 | 0.490 |
Why?
|
Goserelin | 4 | 2020 | 129 | 0.490 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 6 | 2017 | 687 | 0.470 |
Why?
|
Adult | 171 | 2023 | 214052 | 0.460 |
Why?
|
Coronary Circulation | 6 | 2021 | 1572 | 0.450 |
Why?
|
Absorptiometry, Photon | 20 | 2023 | 1725 | 0.430 |
Why?
|
Estrone | 3 | 2023 | 240 | 0.420 |
Why?
|
Mixed Tumor, Mullerian | 6 | 2009 | 56 | 0.420 |
Why?
|
Neointima | 6 | 2015 | 135 | 0.410 |
Why?
|
Rupture, Spontaneous | 11 | 2021 | 354 | 0.410 |
Why?
|
Radius | 8 | 2023 | 422 | 0.410 |
Why?
|
Fibroblast Growth Factors | 7 | 2015 | 878 | 0.400 |
Why?
|
Osteoporosis | 10 | 2017 | 1579 | 0.390 |
Why?
|
Treatment Outcome | 74 | 2024 | 63107 | 0.380 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 18 | 2023 | 11525 | 0.380 |
Why?
|
Estradiol | 9 | 2019 | 2020 | 0.370 |
Why?
|
Fibrinolytic Agents | 6 | 2021 | 2158 | 0.340 |
Why?
|
Alcoholic Intoxication | 3 | 2009 | 188 | 0.330 |
Why?
|
Kidney Transplantation | 5 | 2023 | 4251 | 0.330 |
Why?
|
Genital Neoplasms, Female | 5 | 2022 | 523 | 0.330 |
Why?
|
Tibia | 7 | 2023 | 1077 | 0.320 |
Why?
|
Arteritis | 2 | 2024 | 159 | 0.320 |
Why?
|
Oligomenorrhea | 2 | 2019 | 45 | 0.320 |
Why?
|
Estrogen Replacement Therapy | 4 | 2019 | 1203 | 0.320 |
Why?
|
Staphylococcal Infections | 5 | 2016 | 1400 | 0.320 |
Why?
|
Oxytocin | 2 | 2023 | 394 | 0.310 |
Why?
|
Fractures, Bone | 7 | 2023 | 1947 | 0.310 |
Why?
|
Bone Resorption | 4 | 2019 | 723 | 0.310 |
Why?
|
Stents | 12 | 2022 | 3282 | 0.310 |
Why?
|
Young Adult | 51 | 2023 | 56429 | 0.300 |
Why?
|
Cross Infection | 6 | 2018 | 1417 | 0.300 |
Why?
|
Calcinosis | 4 | 2022 | 1499 | 0.290 |
Why?
|
Libido | 2 | 2020 | 121 | 0.290 |
Why?
|
Adiposity | 5 | 2020 | 1806 | 0.290 |
Why?
|
Adolescent | 67 | 2023 | 85779 | 0.290 |
Why?
|
Coronary Restenosis | 3 | 2015 | 424 | 0.290 |
Why?
|
Starvation | 2 | 2018 | 134 | 0.290 |
Why?
|
Sirolimus | 6 | 2022 | 1565 | 0.290 |
Why?
|
Human Growth Hormone | 4 | 2020 | 683 | 0.280 |
Why?
|
Time Factors | 44 | 2020 | 40075 | 0.280 |
Why?
|
Transplantation Chimera | 2 | 2019 | 613 | 0.280 |
Why?
|
Retrospective Studies | 59 | 2023 | 77460 | 0.280 |
Why?
|
Endothelium, Vascular | 4 | 2021 | 4459 | 0.280 |
Why?
|
Transplantation Tolerance | 3 | 2023 | 617 | 0.280 |
Why?
|
Neoplasm Recurrence, Local | 14 | 2023 | 9240 | 0.270 |
Why?
|
Williams Syndrome | 2 | 2018 | 187 | 0.270 |
Why?
|
Aromatase | 1 | 2005 | 147 | 0.260 |
Why?
|
Follow-Up Studies | 35 | 2021 | 39052 | 0.260 |
Why?
|
Follicle Stimulating Hormone | 4 | 2014 | 744 | 0.260 |
Why?
|
Infection Control | 4 | 2017 | 965 | 0.260 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2020 | 2020 | 0.260 |
Why?
|
Fasting | 3 | 2021 | 1592 | 0.250 |
Why?
|
Neovascularization, Pathologic | 6 | 2016 | 2638 | 0.250 |
Why?
|
Brachytherapy | 2 | 2009 | 1248 | 0.250 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2023 | 1636 | 0.250 |
Why?
|
Cholesterol, LDL | 6 | 2020 | 2355 | 0.240 |
Why?
|
Diabetic Angiopathies | 3 | 2015 | 818 | 0.240 |
Why?
|
Prevalence | 23 | 2020 | 15221 | 0.240 |
Why?
|
Tomography, X-Ray Computed | 20 | 2024 | 20130 | 0.240 |
Why?
|
Neoplasms, Glandular and Epithelial | 3 | 2014 | 484 | 0.240 |
Why?
|
Infertility | 2 | 2023 | 655 | 0.240 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2020 | 4034 | 0.240 |
Why?
|
Cystic Fibrosis | 2 | 2023 | 1178 | 0.240 |
Why?
|
Hospitals, General | 3 | 2017 | 749 | 0.230 |
Why?
|
Enterococcus | 2 | 2017 | 157 | 0.230 |
Why?
|
Hyperthyroidism | 2 | 2023 | 295 | 0.230 |
Why?
|
Adipose Tissue | 7 | 2024 | 3280 | 0.230 |
Why?
|
Adenocarcinoma | 4 | 2020 | 6364 | 0.230 |
Why?
|
Models, Cardiovascular | 3 | 2021 | 996 | 0.230 |
Why?
|
Lipid Metabolism | 5 | 2018 | 1889 | 0.230 |
Why?
|
Parathyroid Hormone | 3 | 2008 | 1800 | 0.230 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2021 | 1018 | 0.230 |
Why?
|
Fibrosis | 11 | 2017 | 2029 | 0.220 |
Why?
|
Graft Occlusion, Vascular | 2 | 2017 | 549 | 0.220 |
Why?
|
Opiate Alkaloids | 1 | 2023 | 26 | 0.220 |
Why?
|
Drug Therapy, Combination | 14 | 2020 | 6489 | 0.220 |
Why?
|
Prognosis | 22 | 2023 | 29060 | 0.220 |
Why?
|
Antineoplastic Agents, Hormonal | 6 | 2019 | 1524 | 0.220 |
Why?
|
Risk Factors | 52 | 2023 | 72296 | 0.220 |
Why?
|
Ghrelin | 2 | 2022 | 266 | 0.220 |
Why?
|
Amino Acids, Branched-Chain | 2 | 2023 | 251 | 0.220 |
Why?
|
Pituitary Diseases | 1 | 2023 | 141 | 0.210 |
Why?
|
Registries | 19 | 2020 | 8091 | 0.210 |
Why?
|
Insulin Resistance | 5 | 2023 | 3864 | 0.210 |
Why?
|
Bacteriological Techniques | 2 | 2014 | 277 | 0.210 |
Why?
|
Insulin-Like Growth Factor I | 7 | 2021 | 2016 | 0.210 |
Why?
|
Serpins | 1 | 2024 | 247 | 0.210 |
Why?
|
Subcutaneous Fat | 3 | 2017 | 391 | 0.210 |
Why?
|
Aging | 7 | 2020 | 8664 | 0.210 |
Why?
|
Obesity | 10 | 2023 | 12746 | 0.210 |
Why?
|
Social Problems | 1 | 2002 | 112 | 0.200 |
Why?
|
Postmenopause | 6 | 2022 | 2460 | 0.200 |
Why?
|
Placebos | 4 | 2019 | 1676 | 0.200 |
Why?
|
Marketing | 1 | 2003 | 212 | 0.200 |
Why?
|
Aromatase Inhibitors | 5 | 2019 | 490 | 0.200 |
Why?
|
Anthozoa | 1 | 2021 | 62 | 0.200 |
Why?
|
Aged, 80 and over | 39 | 2020 | 57776 | 0.200 |
Why?
|
Anticholesteremic Agents | 3 | 2018 | 979 | 0.190 |
Why?
|
Massachusetts | 14 | 2021 | 8662 | 0.190 |
Why?
|
Hypogonadism | 5 | 2009 | 799 | 0.190 |
Why?
|
Myocardial Revascularization | 5 | 2020 | 841 | 0.190 |
Why?
|
Blood Glucose | 9 | 2021 | 6254 | 0.190 |
Why?
|
Hypolipidemic Agents | 2 | 2015 | 604 | 0.190 |
Why?
|
Angiotensins | 2 | 2022 | 151 | 0.190 |
Why?
|
Leuprolide | 3 | 2008 | 321 | 0.190 |
Why?
|
Angina Pectoris | 3 | 2015 | 977 | 0.190 |
Why?
|
Prospective Studies | 33 | 2023 | 53290 | 0.190 |
Why?
|
Diabetes Mellitus | 4 | 2023 | 5749 | 0.190 |
Why?
|
Heparin | 2 | 2021 | 1637 | 0.190 |
Why?
|
Fatty Liver | 2 | 2018 | 727 | 0.190 |
Why?
|
Glaucoma, Open-Angle | 2 | 2019 | 706 | 0.190 |
Why?
|
Thyrotropin | 3 | 2023 | 849 | 0.180 |
Why?
|
Dwarfism, Pituitary | 1 | 2020 | 46 | 0.180 |
Why?
|
Pelvic Bones | 1 | 2022 | 265 | 0.180 |
Why?
|
Infertility, Male | 1 | 2023 | 409 | 0.180 |
Why?
|
Nitriles | 4 | 2009 | 955 | 0.180 |
Why?
|
Peptide Fragments | 6 | 2019 | 5096 | 0.180 |
Why?
|
Blood Donors | 6 | 2011 | 355 | 0.180 |
Why?
|
Quality of Life | 15 | 2022 | 12802 | 0.180 |
Why?
|
Adaptation, Physiological | 2 | 2018 | 1312 | 0.180 |
Why?
|
Growth Hormone | 3 | 2020 | 705 | 0.180 |
Why?
|
Bone Marrow | 2 | 2021 | 2948 | 0.180 |
Why?
|
Ethanol | 3 | 2009 | 1342 | 0.180 |
Why?
|
Spironolactone | 1 | 2023 | 382 | 0.180 |
Why?
|
Tracheal Neoplasms | 1 | 2021 | 124 | 0.180 |
Why?
|
Intra-Abdominal Fat | 4 | 2014 | 591 | 0.180 |
Why?
|
Chi-Square Distribution | 10 | 2017 | 3508 | 0.180 |
Why?
|
Cannabidiol | 1 | 2022 | 106 | 0.180 |
Why?
|
Nerve Fibers | 2 | 2014 | 687 | 0.180 |
Why?
|
Blood Circulation | 1 | 2021 | 251 | 0.180 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2021 | 216 | 0.180 |
Why?
|
Proteomics | 4 | 2024 | 3638 | 0.180 |
Why?
|
Procollagen | 5 | 2016 | 185 | 0.180 |
Why?
|
Tunica Intima | 3 | 2013 | 464 | 0.180 |
Why?
|
Hematoma, Subdural | 1 | 2020 | 126 | 0.170 |
Why?
|
Aspirin | 3 | 2017 | 3283 | 0.170 |
Why?
|
Automobile Driving | 2 | 2009 | 431 | 0.170 |
Why?
|
No-Reflow Phenomenon | 2 | 2016 | 14 | 0.170 |
Why?
|
Reproducibility of Results | 22 | 2020 | 19905 | 0.170 |
Why?
|
Dose-Response Relationship, Drug | 14 | 2020 | 10943 | 0.170 |
Why?
|
Smoking | 6 | 2015 | 8987 | 0.170 |
Why?
|
Fallopian Tube Neoplasms | 5 | 2009 | 324 | 0.170 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2020 | 116 | 0.170 |
Why?
|
Proteome | 2 | 2020 | 1798 | 0.170 |
Why?
|
Longitudinal Studies | 13 | 2023 | 13991 | 0.170 |
Why?
|
Puberty | 3 | 2013 | 490 | 0.170 |
Why?
|
Organizational Policy | 2 | 2017 | 429 | 0.170 |
Why?
|
Double-Blind Method | 15 | 2021 | 12025 | 0.170 |
Why?
|
Kidney Calculi | 2 | 2014 | 465 | 0.170 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2015 | 615 | 0.170 |
Why?
|
Self-Examination | 1 | 1999 | 70 | 0.170 |
Why?
|
Case-Control Studies | 20 | 2020 | 21748 | 0.160 |
Why?
|
Tracheal Stenosis | 1 | 2021 | 226 | 0.160 |
Why?
|
Risk-Taking | 3 | 2002 | 986 | 0.160 |
Why?
|
Collagen Type I | 6 | 2016 | 592 | 0.160 |
Why?
|
Menstrual Cycle | 2 | 2020 | 551 | 0.160 |
Why?
|
Odds Ratio | 13 | 2021 | 9849 | 0.160 |
Why?
|
Hepatitis B | 4 | 2005 | 695 | 0.160 |
Why?
|
Septal Occluder Device | 1 | 2019 | 128 | 0.160 |
Why?
|
Gastrectomy | 4 | 2023 | 663 | 0.160 |
Why?
|
Life Change Events | 2 | 2001 | 938 | 0.160 |
Why?
|
Food, Fortified | 2 | 2018 | 191 | 0.160 |
Why?
|
Hepatitis B Vaccines | 3 | 2005 | 194 | 0.160 |
Why?
|
Prostatic Neoplasms | 8 | 2012 | 11126 | 0.160 |
Why?
|
Spine | 2 | 2023 | 1144 | 0.160 |
Why?
|
Adipose Tissue, Brown | 2 | 2016 | 756 | 0.160 |
Why?
|
Inflammation | 10 | 2024 | 10637 | 0.160 |
Why?
|
Graft Rejection | 3 | 2023 | 4397 | 0.160 |
Why?
|
Estrogens | 2 | 2019 | 1566 | 0.160 |
Why?
|
Menstruation | 2 | 2017 | 302 | 0.160 |
Why?
|
Diphosphonates | 2 | 2017 | 623 | 0.160 |
Why?
|
Hemodynamics | 4 | 2022 | 4196 | 0.160 |
Why?
|
Retinal Ganglion Cells | 2 | 2014 | 770 | 0.160 |
Why?
|
Lacrimal Apparatus Diseases | 1 | 2018 | 65 | 0.160 |
Why?
|
Antithrombins | 1 | 2021 | 304 | 0.160 |
Why?
|
Aortic Valve | 2 | 2020 | 1924 | 0.150 |
Why?
|
Vulvar Neoplasms | 1 | 2020 | 272 | 0.150 |
Why?
|
Luteinizing Hormone | 3 | 2010 | 869 | 0.150 |
Why?
|
Phacoemulsification | 1 | 2019 | 149 | 0.150 |
Why?
|
Glaucoma, Angle-Closure | 1 | 2019 | 189 | 0.150 |
Why?
|
Neoplastic Stem Cells | 2 | 2017 | 1376 | 0.150 |
Why?
|
Anti-Bacterial Agents | 5 | 2018 | 7182 | 0.150 |
Why?
|
Anti-Mullerian Hormone | 1 | 2020 | 402 | 0.150 |
Why?
|
Carboplatin | 7 | 2022 | 801 | 0.150 |
Why?
|
Androgens | 4 | 2019 | 1281 | 0.150 |
Why?
|
Dyslipidemias | 2 | 2020 | 849 | 0.150 |
Why?
|
Disulfiram | 1 | 2017 | 57 | 0.150 |
Why?
|
Probiotics | 1 | 2021 | 351 | 0.150 |
Why?
|
Alphapapillomavirus | 1 | 2020 | 221 | 0.150 |
Why?
|
Thrombectomy | 3 | 2017 | 680 | 0.150 |
Why?
|
Methicillin | 1 | 2017 | 59 | 0.150 |
Why?
|
Drug Administration Schedule | 12 | 2019 | 4933 | 0.150 |
Why?
|
Disease-Free Survival | 11 | 2018 | 6896 | 0.150 |
Why?
|
Models, Genetic | 4 | 1997 | 3493 | 0.150 |
Why?
|
Vancomycin | 2 | 2018 | 501 | 0.150 |
Why?
|
Tracheostomy | 1 | 2021 | 401 | 0.150 |
Why?
|
Thyroid Function Tests | 1 | 2018 | 286 | 0.150 |
Why?
|
Seasons | 3 | 2020 | 1493 | 0.150 |
Why?
|
Microscopy | 1 | 2022 | 902 | 0.150 |
Why?
|
Adipokines | 2 | 2010 | 320 | 0.150 |
Why?
|
Polymerase Chain Reaction | 4 | 2015 | 6171 | 0.150 |
Why?
|
Cross-Sectional Studies | 20 | 2023 | 25039 | 0.140 |
Why?
|
Quinolines | 2 | 2018 | 732 | 0.140 |
Why?
|
Imidazoles | 2 | 2017 | 1206 | 0.140 |
Why?
|
Veins | 1 | 2021 | 770 | 0.140 |
Why?
|
Bone Development | 2 | 2013 | 483 | 0.140 |
Why?
|
Hepatectomy | 1 | 2020 | 550 | 0.140 |
Why?
|
Financing, Personal | 1 | 2019 | 308 | 0.140 |
Why?
|
Drug Eruptions | 1 | 2019 | 297 | 0.140 |
Why?
|
Viral Vaccines | 1 | 2022 | 636 | 0.140 |
Why?
|
Eye Neoplasms | 1 | 2018 | 312 | 0.140 |
Why?
|
Neural Tube Defects | 1 | 2018 | 256 | 0.140 |
Why?
|
Disability Evaluation | 3 | 2020 | 1828 | 0.140 |
Why?
|
Eunuchism | 1 | 2016 | 19 | 0.140 |
Why?
|
Phosphates | 3 | 2009 | 785 | 0.140 |
Why?
|
Heart Rupture, Post-Infarction | 1 | 2016 | 49 | 0.140 |
Why?
|
Peritoneal Neoplasms | 5 | 2009 | 665 | 0.140 |
Why?
|
Angioscopy | 1 | 2015 | 49 | 0.140 |
Why?
|
Housing | 1 | 2001 | 664 | 0.140 |
Why?
|
Vascular Resistance | 1 | 2019 | 936 | 0.140 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2018 | 252 | 0.140 |
Why?
|
Fibromyalgia | 1 | 2020 | 388 | 0.140 |
Why?
|
Folic Acid | 2 | 2018 | 1300 | 0.140 |
Why?
|
Pituitary Gland | 2 | 2010 | 665 | 0.130 |
Why?
|
Polyglactin 910 | 1 | 2016 | 59 | 0.130 |
Why?
|
Hepatitis B Core Antigens | 3 | 2005 | 92 | 0.130 |
Why?
|
Liver | 4 | 2019 | 7475 | 0.130 |
Why?
|
Troponin T | 2 | 2011 | 754 | 0.130 |
Why?
|
Atrial Appendage | 1 | 2019 | 283 | 0.130 |
Why?
|
Graft Survival | 3 | 2023 | 3737 | 0.130 |
Why?
|
Risk Assessment | 21 | 2021 | 23336 | 0.130 |
Why?
|
Keratinocytes | 1 | 2019 | 799 | 0.130 |
Why?
|
Neurologic Examination | 1 | 1999 | 931 | 0.130 |
Why?
|
Hepatitis B Antibodies | 3 | 2005 | 159 | 0.130 |
Why?
|
Blood Proteins | 1 | 2020 | 1124 | 0.130 |
Why?
|
Neoplasms | 6 | 2022 | 21696 | 0.130 |
Why?
|
Thrombosis | 3 | 2020 | 2968 | 0.130 |
Why?
|
Cortical Spreading Depression | 1 | 2019 | 276 | 0.130 |
Why?
|
Cataract Extraction | 1 | 2019 | 481 | 0.130 |
Why?
|
Homocysteine | 3 | 2022 | 647 | 0.130 |
Why?
|
Reproduction | 1 | 2020 | 668 | 0.130 |
Why?
|
Penicillins | 1 | 2018 | 380 | 0.130 |
Why?
|
Multiple Sclerosis | 3 | 2013 | 3079 | 0.130 |
Why?
|
Multivariate Analysis | 14 | 2016 | 12244 | 0.130 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2018 | 349 | 0.130 |
Why?
|
Phthalazines | 2 | 2014 | 363 | 0.130 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2013 | 1873 | 0.130 |
Why?
|
United States | 27 | 2020 | 69872 | 0.130 |
Why?
|
Paclitaxel | 8 | 2022 | 1708 | 0.120 |
Why?
|
Quinazolines | 4 | 2022 | 1356 | 0.120 |
Why?
|
Verbal Learning | 1 | 2017 | 468 | 0.120 |
Why?
|
Administration, Cutaneous | 5 | 2020 | 711 | 0.120 |
Why?
|
Lymphocyte Subsets | 2 | 1993 | 315 | 0.120 |
Why?
|
Serum | 1 | 2016 | 214 | 0.120 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2014 | 15 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 2 | 2016 | 1790 | 0.120 |
Why?
|
Administration, Oral | 7 | 2019 | 3914 | 0.120 |
Why?
|
Single-Blind Method | 5 | 2017 | 1590 | 0.120 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 7914 | 0.120 |
Why?
|
Endometrial Neoplasms | 4 | 2013 | 1351 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2012 | 1677 | 0.120 |
Why?
|
Ankle Injuries | 1 | 2018 | 331 | 0.120 |
Why?
|
Hip Fractures | 1 | 2022 | 955 | 0.120 |
Why?
|
Nephrocalcinosis | 1 | 2014 | 48 | 0.120 |
Why?
|
Cerebral Cortex | 3 | 2019 | 5709 | 0.120 |
Why?
|
Stress, Mechanical | 4 | 2022 | 1686 | 0.120 |
Why?
|
Carcinoma, Basal Cell | 1 | 2019 | 545 | 0.120 |
Why?
|
Hydrodynamics | 3 | 2021 | 158 | 0.120 |
Why?
|
Androgen Antagonists | 3 | 2008 | 1377 | 0.120 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2015 | 402 | 0.120 |
Why?
|
Immunoglobulin G | 3 | 2023 | 4561 | 0.120 |
Why?
|
Antipsychotic Agents | 4 | 2019 | 3057 | 0.120 |
Why?
|
Neoplasm Staging | 10 | 2023 | 11031 | 0.120 |
Why?
|
Acupuncture Therapy | 2 | 2009 | 464 | 0.120 |
Why?
|
Triage | 2 | 2012 | 977 | 0.120 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2019 | 745 | 0.110 |
Why?
|
Psoriasis | 2 | 2012 | 902 | 0.110 |
Why?
|
Triazoles | 2 | 2009 | 908 | 0.110 |
Why?
|
Hypercholesterolemia | 1 | 2020 | 1151 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2021 | 941 | 0.110 |
Why?
|
Sex Factors | 11 | 2020 | 10400 | 0.110 |
Why?
|
Patient Transfer | 2 | 2017 | 762 | 0.110 |
Why?
|
Anilides | 2 | 2008 | 408 | 0.110 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2020 | 3070 | 0.110 |
Why?
|
Sialoglycoproteins | 2 | 2004 | 318 | 0.110 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5263 | 0.110 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2017 | 3326 | 0.110 |
Why?
|
Age Factors | 15 | 2020 | 18373 | 0.110 |
Why?
|
Sentinel Surveillance | 1 | 2015 | 281 | 0.110 |
Why?
|
Fractures, Stress | 1 | 2015 | 187 | 0.110 |
Why?
|
Travel | 1 | 2019 | 788 | 0.110 |
Why?
|
Solitary Fibrous Tumor, Pleural | 1 | 2012 | 25 | 0.110 |
Why?
|
Executive Function | 2 | 2022 | 1364 | 0.110 |
Why?
|
Body Weight | 4 | 2018 | 4671 | 0.110 |
Why?
|
Blood Coagulation Disorders | 2 | 1993 | 337 | 0.110 |
Why?
|
Adenosine | 1 | 2017 | 825 | 0.110 |
Why?
|
Lipoproteins, LDL | 1 | 2016 | 640 | 0.110 |
Why?
|
Sex Characteristics | 3 | 2023 | 2585 | 0.110 |
Why?
|
Intubation, Intratracheal | 1 | 2021 | 1364 | 0.110 |
Why?
|
Ventricular Fibrillation | 1 | 2015 | 538 | 0.110 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 639 | 0.110 |
Why?
|
Mental Recall | 2 | 2017 | 1206 | 0.110 |
Why?
|
Residence Characteristics | 1 | 2002 | 2050 | 0.110 |
Why?
|
Feedback, Physiological | 3 | 2010 | 479 | 0.110 |
Why?
|
Mass Spectrometry | 2 | 2017 | 2204 | 0.110 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2013 | 85 | 0.110 |
Why?
|
Obesity, Morbid | 1 | 2023 | 1213 | 0.110 |
Why?
|
Patient Participation | 2 | 2019 | 1457 | 0.110 |
Why?
|
Visual Cortex | 1 | 2020 | 1149 | 0.110 |
Why?
|
Algorithms | 7 | 2020 | 13882 | 0.100 |
Why?
|
Oligopeptides | 1 | 2018 | 1189 | 0.100 |
Why?
|
Acquired Immunodeficiency Syndrome | 4 | 1995 | 2232 | 0.100 |
Why?
|
Finite Element Analysis | 4 | 2015 | 431 | 0.100 |
Why?
|
Incidence | 12 | 2020 | 20952 | 0.100 |
Why?
|
Catheter-Related Infections | 1 | 2015 | 252 | 0.100 |
Why?
|
Heart Injuries | 1 | 2014 | 210 | 0.100 |
Why?
|
Arthroscopy | 1 | 2018 | 926 | 0.100 |
Why?
|
Menopause | 1 | 2020 | 1626 | 0.100 |
Why?
|
Combined Modality Therapy | 10 | 2021 | 8642 | 0.100 |
Why?
|
Angina, Unstable | 1 | 2016 | 926 | 0.100 |
Why?
|
Hypertension | 3 | 2022 | 8479 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 8 | 2017 | 6539 | 0.100 |
Why?
|
Transplantation Conditioning | 1 | 2019 | 1599 | 0.100 |
Why?
|
Vancomycin Resistance | 1 | 2012 | 128 | 0.100 |
Why?
|
Metabolome | 1 | 2018 | 895 | 0.100 |
Why?
|
Education | 1 | 2015 | 543 | 0.100 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2011 | 31 | 0.100 |
Why?
|
Gonadotropins | 2 | 2010 | 241 | 0.100 |
Why?
|
Uterine Neoplasms | 3 | 2008 | 1513 | 0.100 |
Why?
|
Severity of Illness Index | 11 | 2021 | 15535 | 0.100 |
Why?
|
Hip | 1 | 2013 | 257 | 0.100 |
Why?
|
Immunosuppressive Agents | 4 | 2019 | 4153 | 0.100 |
Why?
|
Thermogenesis | 1 | 2015 | 434 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2021 | 1239 | 0.100 |
Why?
|
Alcoholism | 1 | 2002 | 1906 | 0.100 |
Why?
|
Arginine Vasopressin | 1 | 2011 | 130 | 0.100 |
Why?
|
Cohort Studies | 15 | 2021 | 40559 | 0.100 |
Why?
|
Hospital Administration | 1 | 2015 | 353 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 4 | 2019 | 4042 | 0.100 |
Why?
|
Colitis | 1 | 2019 | 1170 | 0.100 |
Why?
|
Joint Instability | 1 | 2018 | 792 | 0.100 |
Why?
|
Nasal Mucosa | 1 | 2014 | 373 | 0.100 |
Why?
|
Lumbar Vertebrae | 3 | 2017 | 1848 | 0.100 |
Why?
|
Warfarin | 1 | 2019 | 1497 | 0.100 |
Why?
|
Logistic Models | 9 | 2020 | 13409 | 0.100 |
Why?
|
Inhibins | 2 | 2009 | 211 | 0.100 |
Why?
|
Cardiovascular System | 1 | 2018 | 831 | 0.100 |
Why?
|
Body Mass Index | 10 | 2023 | 12721 | 0.100 |
Why?
|
Cholesterol | 2 | 2023 | 2919 | 0.100 |
Why?
|
CA-125 Antigen | 4 | 2009 | 286 | 0.100 |
Why?
|
Sensitivity and Specificity | 11 | 2015 | 14723 | 0.090 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2019 | 1572 | 0.090 |
Why?
|
Adenoma | 2 | 2011 | 2174 | 0.090 |
Why?
|
HIV | 3 | 2023 | 1604 | 0.090 |
Why?
|
Plasma Cells | 1 | 2014 | 591 | 0.090 |
Why?
|
Genetics, Population | 1 | 1996 | 934 | 0.090 |
Why?
|
HIV-1 | 9 | 2008 | 6939 | 0.090 |
Why?
|
Survival Rate | 6 | 2021 | 12788 | 0.090 |
Why?
|
Fibronectins | 1 | 2014 | 726 | 0.090 |
Why?
|
Observer Variation | 5 | 2017 | 2593 | 0.090 |
Why?
|
Boston | 9 | 2016 | 9312 | 0.090 |
Why?
|
Cardiovascular Diseases | 5 | 2023 | 15160 | 0.090 |
Why?
|
Primates | 2 | 2023 | 545 | 0.090 |
Why?
|
Metabolomics | 2 | 2018 | 1485 | 0.090 |
Why?
|
Tosyl Compounds | 2 | 2008 | 113 | 0.090 |
Why?
|
Neuromuscular Diseases | 1 | 2013 | 247 | 0.090 |
Why?
|
Bariatric Surgery | 1 | 2020 | 952 | 0.090 |
Why?
|
Optic Nerve Diseases | 1 | 2014 | 327 | 0.090 |
Why?
|
Seminiferous Tubules | 1 | 2009 | 26 | 0.090 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2010 | 57 | 0.090 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2013 | 664 | 0.090 |
Why?
|
Survivors | 3 | 2010 | 2291 | 0.090 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2014 | 547 | 0.090 |
Why?
|
Child | 21 | 2023 | 77709 | 0.090 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2010 | 92 | 0.090 |
Why?
|
Blood Platelets | 1 | 2021 | 2509 | 0.090 |
Why?
|
Hepatitis B virus | 2 | 2003 | 513 | 0.090 |
Why?
|
Social Behavior | 3 | 2009 | 1127 | 0.090 |
Why?
|
Attitude | 1 | 2015 | 776 | 0.090 |
Why?
|
Neuroma, Acoustic | 1 | 2014 | 451 | 0.090 |
Why?
|
Glycopeptides | 1 | 2011 | 226 | 0.090 |
Why?
|
Sports | 1 | 2016 | 688 | 0.090 |
Why?
|
Electrocardiography | 4 | 2019 | 6442 | 0.090 |
Why?
|
Substance-Related Disorders | 3 | 2023 | 4257 | 0.090 |
Why?
|
Pyrazines | 1 | 2015 | 1230 | 0.090 |
Why?
|
Adolescent Development | 1 | 2013 | 279 | 0.090 |
Why?
|
Genomic Imprinting | 1 | 2011 | 328 | 0.090 |
Why?
|
Japan | 4 | 2020 | 1360 | 0.090 |
Why?
|
Cerebral Infarction | 1 | 2014 | 1011 | 0.090 |
Why?
|
Peptides | 6 | 2016 | 4410 | 0.090 |
Why?
|
Enterobacteriaceae | 1 | 2010 | 169 | 0.090 |
Why?
|
Optic Disk | 1 | 2013 | 400 | 0.090 |
Why?
|
Obesity, Abdominal | 1 | 2012 | 361 | 0.090 |
Why?
|
Aortic Diseases | 1 | 2015 | 743 | 0.090 |
Why?
|
Attitude to Health | 1 | 1998 | 2052 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 840 | 0.090 |
Why?
|
Muscle Strength | 1 | 2013 | 592 | 0.080 |
Why?
|
Neurosurgical Procedures | 1 | 2020 | 2002 | 0.080 |
Why?
|
Drug Hypersensitivity | 1 | 2018 | 884 | 0.080 |
Why?
|
Drug Resistance | 1 | 2015 | 1608 | 0.080 |
Why?
|
Donor Selection | 1 | 2011 | 201 | 0.080 |
Why?
|
beta-Lactams | 1 | 2010 | 160 | 0.080 |
Why?
|
Fibrinogen | 2 | 2022 | 894 | 0.080 |
Why?
|
Interviews as Topic | 2 | 2009 | 2539 | 0.080 |
Why?
|
Phenotype | 7 | 2017 | 16367 | 0.080 |
Why?
|
Radioimmunoassay | 3 | 2010 | 919 | 0.080 |
Why?
|
Receptors, Progesterone | 2 | 2013 | 1098 | 0.080 |
Why?
|
Neuropsychological Tests | 4 | 2022 | 6994 | 0.080 |
Why?
|
Infusions, Intravenous | 5 | 2019 | 2274 | 0.080 |
Why?
|
Heart | 2 | 2024 | 4464 | 0.080 |
Why?
|
Diagnosis, Differential | 8 | 2018 | 12961 | 0.080 |
Why?
|
Urinary Tract Infections | 1 | 2015 | 788 | 0.080 |
Why?
|
Prosthesis Failure | 2 | 2014 | 1206 | 0.080 |
Why?
|
Enterobacteriaceae Infections | 1 | 2010 | 187 | 0.080 |
Why?
|
Urinary Calculi | 1 | 2009 | 91 | 0.080 |
Why?
|
Cardiac Volume | 1 | 2009 | 210 | 0.080 |
Why?
|
Antibodies, Monoclonal | 4 | 2023 | 9274 | 0.080 |
Why?
|
Drug Prescriptions | 2 | 2015 | 1637 | 0.080 |
Why?
|
Atrial Fibrillation | 2 | 2019 | 5035 | 0.080 |
Why?
|
Seminiferous Epithelium | 1 | 2008 | 9 | 0.080 |
Why?
|
Osteocalcin | 2 | 2006 | 273 | 0.080 |
Why?
|
Papillomavirus Infections | 1 | 2020 | 1587 | 0.080 |
Why?
|
Hyperplasia | 4 | 2013 | 1185 | 0.080 |
Why?
|
Gonadal Steroid Hormones | 2 | 2014 | 711 | 0.080 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1540 | 0.080 |
Why?
|
Sick Role | 2 | 1999 | 237 | 0.080 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2013 | 602 | 0.080 |
Why?
|
Genetic Linkage | 3 | 1998 | 2421 | 0.080 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2013 | 721 | 0.080 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2010 | 595 | 0.080 |
Why?
|
Microspheres | 1 | 2011 | 777 | 0.080 |
Why?
|
CD4 Lymphocyte Count | 4 | 2020 | 2560 | 0.080 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2009 | 369 | 0.080 |
Why?
|
HLA Antigens | 2 | 2011 | 1382 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2020 | 2530 | 0.080 |
Why?
|
Carcinoma, Papillary | 2 | 2011 | 783 | 0.080 |
Why?
|
Cushing Syndrome | 1 | 2009 | 249 | 0.080 |
Why?
|
Terminal Care | 1 | 2020 | 1694 | 0.080 |
Why?
|
Cystadenocarcinoma, Serous | 2 | 2009 | 450 | 0.080 |
Why?
|
Burkitt Lymphoma | 1 | 2010 | 327 | 0.080 |
Why?
|
Anticoagulants | 2 | 2021 | 4600 | 0.080 |
Why?
|
Pilot Projects | 6 | 2021 | 8319 | 0.080 |
Why?
|
Pleural Neoplasms | 1 | 2012 | 607 | 0.080 |
Why?
|
Population Surveillance | 1 | 2018 | 2616 | 0.080 |
Why?
|
ROC Curve | 5 | 2016 | 3528 | 0.080 |
Why?
|
Aortic Valve Stenosis | 1 | 2020 | 1965 | 0.080 |
Why?
|
Heart Valve Diseases | 1 | 2015 | 1074 | 0.080 |
Why?
|
Prosthesis Design | 4 | 2016 | 2110 | 0.070 |
Why?
|
Anabolic Agents | 1 | 2010 | 247 | 0.070 |
Why?
|
Osteopathic Medicine | 1 | 2007 | 14 | 0.070 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 1 | 2008 | 138 | 0.070 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2009 | 221 | 0.070 |
Why?
|
Injections, Subcutaneous | 3 | 2020 | 667 | 0.070 |
Why?
|
HIV Seropositivity | 5 | 2005 | 971 | 0.070 |
Why?
|
Overweight | 1 | 2018 | 2371 | 0.070 |
Why?
|
Mammary Arteries | 1 | 2007 | 70 | 0.070 |
Why?
|
Immunotherapy | 2 | 2020 | 4446 | 0.070 |
Why?
|
Pelvic Infection | 1 | 2006 | 12 | 0.070 |
Why?
|
Stroke Volume | 1 | 2020 | 5006 | 0.070 |
Why?
|
Hirudins | 2 | 2021 | 183 | 0.070 |
Why?
|
Macaca fascicularis | 2 | 2019 | 915 | 0.070 |
Why?
|
Regression Analysis | 6 | 2013 | 6459 | 0.070 |
Why?
|
Area Under Curve | 4 | 2016 | 1655 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 11726 | 0.070 |
Why?
|
Visual Fields | 1 | 2014 | 1047 | 0.070 |
Why?
|
Protein Precursors | 1 | 2011 | 1154 | 0.070 |
Why?
|
Piperazines | 2 | 2014 | 2488 | 0.070 |
Why?
|
Aneurysm | 1 | 2010 | 339 | 0.070 |
Why?
|
Cardiovascular Agents | 1 | 2013 | 850 | 0.070 |
Why?
|
Isoantibodies | 1 | 2011 | 679 | 0.070 |
Why?
|
Emergency Service, Hospital | 4 | 2015 | 7658 | 0.070 |
Why?
|
Phosphorus | 1 | 2008 | 338 | 0.070 |
Why?
|
Osteogenesis | 1 | 2014 | 1299 | 0.070 |
Why?
|
California | 5 | 2017 | 1402 | 0.070 |
Why?
|
Tachycardia, Ventricular | 1 | 2015 | 1273 | 0.070 |
Why?
|
Vision Disorders | 1 | 2014 | 1058 | 0.070 |
Why?
|
Angioplasty, Balloon | 1 | 2011 | 653 | 0.070 |
Why?
|
Anti-HIV Agents | 3 | 2020 | 4255 | 0.070 |
Why?
|
Health | 1 | 2009 | 394 | 0.070 |
Why?
|
Psychotropic Drugs | 1 | 2012 | 894 | 0.070 |
Why?
|
Leukopenia | 1 | 2007 | 213 | 0.070 |
Why?
|
Linear Models | 5 | 2017 | 5953 | 0.070 |
Why?
|
Cardiomegaly | 1 | 2009 | 620 | 0.070 |
Why?
|
Postprandial Period | 1 | 2008 | 292 | 0.070 |
Why?
|
Comorbidity | 7 | 2020 | 10388 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2020 | 3265 | 0.070 |
Why?
|
Schizophrenia | 6 | 2002 | 6882 | 0.070 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2009 | 903 | 0.070 |
Why?
|
Fluorouracil | 2 | 2023 | 1619 | 0.070 |
Why?
|
Reference Values | 4 | 2018 | 4982 | 0.070 |
Why?
|
Bacteremia | 1 | 2013 | 963 | 0.070 |
Why?
|
Pertussis Vaccine | 1 | 2005 | 34 | 0.070 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2408 | 0.070 |
Why?
|
Bordetella pertussis | 1 | 2005 | 43 | 0.070 |
Why?
|
Gene Frequency | 1 | 1993 | 3587 | 0.070 |
Why?
|
Wound Healing | 2 | 2015 | 2785 | 0.070 |
Why?
|
China | 3 | 2017 | 2245 | 0.070 |
Why?
|
Multiple Birth Offspring | 1 | 2005 | 21 | 0.070 |
Why?
|
Adaptation, Psychological | 3 | 2010 | 2575 | 0.070 |
Why?
|
Kidney Failure, Chronic | 2 | 2008 | 2535 | 0.070 |
Why?
|
Receptors, Estrogen | 2 | 2013 | 2190 | 0.060 |
Why?
|
Cocaine-Related Disorders | 1 | 2008 | 460 | 0.060 |
Why?
|
Thyroxine | 2 | 2023 | 667 | 0.060 |
Why?
|
Diabetes, Gestational | 1 | 2015 | 1184 | 0.060 |
Why?
|
Acromegaly | 1 | 2008 | 347 | 0.060 |
Why?
|
Blood Vessel Prosthesis | 1 | 2010 | 934 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3047 | 0.060 |
Why?
|
Whooping Cough | 1 | 2005 | 82 | 0.060 |
Why?
|
Abdominal Abscess | 1 | 2006 | 154 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5445 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2017 | 3589 | 0.060 |
Why?
|
Crohn Disease | 2 | 2009 | 2304 | 0.060 |
Why?
|
Metformin | 1 | 2012 | 836 | 0.060 |
Why?
|
Adiponectin | 4 | 2015 | 1101 | 0.060 |
Why?
|
Thyroid Gland | 1 | 2011 | 1173 | 0.060 |
Why?
|
Gene Silencing | 1 | 2011 | 1539 | 0.060 |
Why?
|
Interleukin-6 | 3 | 2022 | 3203 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2278 | 0.060 |
Why?
|
Acute Lung Injury | 1 | 2008 | 380 | 0.060 |
Why?
|
Patient Admission | 1 | 2012 | 1380 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2012 | 7882 | 0.060 |
Why?
|
Thyroid Nodule | 1 | 2011 | 750 | 0.060 |
Why?
|
Dialysis | 1 | 2004 | 75 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2010 | 988 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2019 | 13035 | 0.060 |
Why?
|
Confidence Intervals | 4 | 2014 | 2971 | 0.060 |
Why?
|
Computer Simulation | 2 | 2014 | 6194 | 0.060 |
Why?
|
Thrombolytic Therapy | 1 | 2013 | 2162 | 0.060 |
Why?
|
Models, Statistical | 2 | 1997 | 5101 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4253 | 0.060 |
Why?
|
Neutropenia | 1 | 2009 | 895 | 0.060 |
Why?
|
Animals | 13 | 2023 | 168768 | 0.060 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2004 | 129 | 0.060 |
Why?
|
Homocystine | 1 | 2003 | 22 | 0.060 |
Why?
|
Glucose Tolerance Test | 3 | 2015 | 1151 | 0.060 |
Why?
|
Receptor, erbB-2 | 2 | 2013 | 2417 | 0.060 |
Why?
|
Pedigree | 5 | 2007 | 4642 | 0.060 |
Why?
|
Drug Substitution | 2 | 2017 | 281 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2013 | 2038 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2009 | 970 | 0.060 |
Why?
|
Siblings | 1 | 2008 | 854 | 0.060 |
Why?
|
Endovascular Procedures | 1 | 2017 | 1980 | 0.060 |
Why?
|
Lymphoma, B-Cell | 1 | 2010 | 931 | 0.060 |
Why?
|
Deoxycytidine | 2 | 2006 | 826 | 0.060 |
Why?
|
Food Industry | 1 | 2003 | 68 | 0.060 |
Why?
|
Viral Load | 3 | 2020 | 3300 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2017 | 2200 | 0.060 |
Why?
|
Emotions | 1 | 2015 | 2659 | 0.060 |
Why?
|
Pregnancy | 6 | 2024 | 29144 | 0.060 |
Why?
|
Neisseria meningitidis | 1 | 2003 | 109 | 0.060 |
Why?
|
Quality of Health Care | 1 | 1998 | 4369 | 0.060 |
Why?
|
Mathematics | 2 | 1996 | 728 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2017 | 8432 | 0.060 |
Why?
|
Genes, bcl-2 | 1 | 2023 | 122 | 0.050 |
Why?
|
Radiotherapy Dosage | 1 | 2009 | 2879 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1434 | 0.050 |
Why?
|
Agonistic Behavior | 1 | 2002 | 15 | 0.050 |
Why?
|
Androstenedione | 1 | 2002 | 131 | 0.050 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2024 | 164 | 0.050 |
Why?
|
Lower Extremity | 1 | 2011 | 1158 | 0.050 |
Why?
|
Meningococcal Vaccines | 1 | 2003 | 95 | 0.050 |
Why?
|
Blood Transfusion | 2 | 2008 | 1301 | 0.050 |
Why?
|
Age Determination by Skeleton | 2 | 2013 | 129 | 0.050 |
Why?
|
Pituitary Neoplasms | 1 | 2011 | 1345 | 0.050 |
Why?
|
Republic of Korea | 2 | 2015 | 538 | 0.050 |
Why?
|
Patient Selection | 4 | 2020 | 4216 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2006 | 791 | 0.050 |
Why?
|
Self Disclosure | 1 | 2003 | 251 | 0.050 |
Why?
|
Risk | 4 | 2019 | 9688 | 0.050 |
Why?
|
Health Services Accessibility | 2 | 2016 | 5135 | 0.050 |
Why?
|
Prothrombin | 1 | 2022 | 185 | 0.050 |
Why?
|
Leiomyoma | 1 | 2008 | 730 | 0.050 |
Why?
|
Dexamethasone | 1 | 2009 | 1951 | 0.050 |
Why?
|
Receptors, Angiotensin | 1 | 2022 | 142 | 0.050 |
Why?
|
STAT3 Transcription Factor | 1 | 2006 | 874 | 0.050 |
Why?
|
Macrophages | 3 | 2022 | 5660 | 0.050 |
Why?
|
Social Environment | 2 | 2002 | 1022 | 0.050 |
Why?
|
Calcium | 4 | 2009 | 5755 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2134 | 0.050 |
Why?
|
Chimerism | 1 | 2023 | 158 | 0.050 |
Why?
|
Proportional Hazards Models | 6 | 2015 | 12356 | 0.050 |
Why?
|
Poliovirus Vaccine, Inactivated | 1 | 2001 | 24 | 0.050 |
Why?
|
Hypothalamus | 1 | 2007 | 1063 | 0.050 |
Why?
|
Pirenzepine | 1 | 2002 | 115 | 0.050 |
Why?
|
Leucovorin | 1 | 2023 | 628 | 0.050 |
Why?
|
Leucine | 1 | 2023 | 560 | 0.050 |
Why?
|
Vitamin B 6 | 1 | 2003 | 237 | 0.050 |
Why?
|
Disease Progression | 6 | 2017 | 13286 | 0.050 |
Why?
|
Genetic Loci | 1 | 2011 | 2575 | 0.050 |
Why?
|
Lactobacillus plantarum | 1 | 2021 | 5 | 0.050 |
Why?
|
Ischemia | 1 | 2011 | 1907 | 0.050 |
Why?
|
Mass Screening | 2 | 2013 | 5253 | 0.050 |
Why?
|
Cholesterol, HDL | 2 | 2022 | 1813 | 0.050 |
Why?
|
Leukocyte Count | 2 | 2020 | 1588 | 0.050 |
Why?
|
Urinary Bladder | 1 | 2008 | 1173 | 0.050 |
Why?
|
Prone Position | 1 | 2022 | 194 | 0.050 |
Why?
|
Vaccines, Conjugate | 1 | 2003 | 333 | 0.050 |
Why?
|
Tunica Media | 2 | 2015 | 113 | 0.050 |
Why?
|
Cisplatin | 2 | 2020 | 1662 | 0.050 |
Why?
|
Age Distribution | 3 | 2015 | 2902 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 5 | 2020 | 35425 | 0.050 |
Why?
|
Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2001 | 31 | 0.050 |
Why?
|
Vitamin D | 3 | 2013 | 3224 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 3873 | 0.050 |
Why?
|
Carbohydrates | 1 | 2023 | 394 | 0.050 |
Why?
|
Recombinant Proteins | 3 | 2021 | 6621 | 0.050 |
Why?
|
Rotavirus Vaccines | 1 | 2002 | 61 | 0.050 |
Why?
|
Random Allocation | 2 | 2017 | 2428 | 0.050 |
Why?
|
Intraocular Pressure | 2 | 2019 | 1270 | 0.050 |
Why?
|
CD40 Ligand | 1 | 2023 | 526 | 0.050 |
Why?
|
C-Reactive Protein | 3 | 2022 | 3778 | 0.050 |
Why?
|
Insulin | 4 | 2023 | 6582 | 0.050 |
Why?
|
Rotavirus Infections | 1 | 2002 | 86 | 0.050 |
Why?
|
Rotarod Performance Test | 1 | 2020 | 64 | 0.050 |
Why?
|
Radiography | 4 | 2015 | 7023 | 0.050 |
Why?
|
Intussusception | 1 | 2002 | 114 | 0.050 |
Why?
|
Microcirculation | 2 | 2016 | 1287 | 0.050 |
Why?
|
Drainage | 1 | 2006 | 1142 | 0.050 |
Why?
|
Stroke | 2 | 2019 | 9981 | 0.050 |
Why?
|
Ovariectomy | 2 | 2019 | 661 | 0.050 |
Why?
|
Deltaretrovirus Infections | 2 | 1991 | 26 | 0.050 |
Why?
|
Probability | 2 | 1997 | 2506 | 0.050 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2005 | 482 | 0.050 |
Why?
|
Weight Gain | 2 | 2023 | 2293 | 0.050 |
Why?
|
Haloperidol | 1 | 2002 | 397 | 0.050 |
Why?
|
Pipecolic Acids | 1 | 2021 | 76 | 0.050 |
Why?
|
Nasopharynx | 1 | 2003 | 379 | 0.050 |
Why?
|
Curettage | 1 | 2020 | 73 | 0.050 |
Why?
|
Topotecan | 3 | 2006 | 137 | 0.050 |
Why?
|
Viremia | 1 | 2003 | 736 | 0.050 |
Why?
|
Bile Acids and Salts | 1 | 2022 | 368 | 0.050 |
Why?
|
Zimbabwe | 1 | 2020 | 129 | 0.050 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2003 | 404 | 0.050 |
Why?
|
Losartan | 1 | 2022 | 299 | 0.050 |
Why?
|
Penile Erection | 1 | 2020 | 97 | 0.050 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2001 | 281 | 0.050 |
Why?
|
Life Style | 1 | 2012 | 3835 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2014 | 8949 | 0.050 |
Why?
|
Hysterectomy | 1 | 2006 | 927 | 0.050 |
Why?
|
Socioeconomic Factors | 5 | 2020 | 7785 | 0.050 |
Why?
|
Recurrence | 4 | 2017 | 8340 | 0.050 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2010 | 1391 | 0.050 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 206 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6773 | 0.040 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2010 | 1378 | 0.040 |
Why?
|
Carcinoma | 1 | 2011 | 2375 | 0.040 |
Why?
|
Peripheral Arterial Disease | 1 | 2011 | 1188 | 0.040 |
Why?
|
Proteins | 2 | 2014 | 6100 | 0.040 |
Why?
|
Prednisone | 1 | 2004 | 1574 | 0.040 |
Why?
|
Maximum Tolerated Dose | 2 | 2014 | 892 | 0.040 |
Why?
|
Electroencephalography | 3 | 2022 | 6151 | 0.040 |
Why?
|
Abdominal Fat | 2 | 2014 | 223 | 0.040 |
Why?
|
Data Collection | 3 | 2012 | 3339 | 0.040 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2020 | 1872 | 0.040 |
Why?
|
Quality Improvement | 1 | 2015 | 3749 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2012 | 2873 | 0.040 |
Why?
|
Leiomyosarcoma | 1 | 2004 | 477 | 0.040 |
Why?
|
Acute Disease | 4 | 2012 | 7147 | 0.040 |
Why?
|
Neurons | 1 | 2019 | 9340 | 0.040 |
Why?
|
Pneumococcal Vaccines | 1 | 2003 | 391 | 0.040 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2021 | 323 | 0.040 |
Why?
|
Likelihood Functions | 2 | 1993 | 1005 | 0.040 |
Why?
|
Infant Mortality | 1 | 2004 | 754 | 0.040 |
Why?
|
Kidney | 3 | 2023 | 7184 | 0.040 |
Why?
|
Dietary Fats | 1 | 2007 | 2016 | 0.040 |
Why?
|
Gels | 1 | 2020 | 427 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 634 | 0.040 |
Why?
|
Survival Analysis | 4 | 2016 | 10252 | 0.040 |
Why?
|
Treatment Failure | 2 | 2017 | 2618 | 0.040 |
Why?
|
Drug Administration Routes | 1 | 2019 | 153 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2022 | 2917 | 0.040 |
Why?
|
GATA3 Transcription Factor | 1 | 2019 | 157 | 0.040 |
Why?
|
Regional Blood Flow | 2 | 2014 | 1525 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1360 | 0.040 |
Why?
|
Drug Interactions | 3 | 2010 | 1460 | 0.040 |
Why?
|
Cognition Disorders | 2 | 2007 | 4043 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2008 | 1783 | 0.040 |
Why?
|
Desogestrel | 1 | 2018 | 23 | 0.040 |
Why?
|
Glucose | 2 | 2023 | 4398 | 0.040 |
Why?
|
Body Fat Distribution | 1 | 2020 | 244 | 0.040 |
Why?
|
Infusions, Parenteral | 1 | 2019 | 419 | 0.040 |
Why?
|
Sepsis | 1 | 2013 | 2593 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2022 | 954 | 0.040 |
Why?
|
Transdermal Patch | 1 | 2018 | 51 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2022 | 5077 | 0.040 |
Why?
|
Maze Learning | 1 | 2020 | 478 | 0.040 |
Why?
|
Breast Neoplasms | 3 | 2014 | 20824 | 0.040 |
Why?
|
Colorado | 1 | 1998 | 163 | 0.040 |
Why?
|
Pneumococcal Infections | 1 | 2003 | 497 | 0.040 |
Why?
|
Edema | 1 | 2022 | 789 | 0.040 |
Why?
|
Appetite Stimulants | 1 | 2018 | 13 | 0.040 |
Why?
|
Thyroid Neoplasms | 1 | 2011 | 2282 | 0.040 |
Why?
|
Neurites | 1 | 2020 | 388 | 0.040 |
Why?
|
Platelet-Rich Plasma | 1 | 2021 | 177 | 0.040 |
Why?
|
Skin Diseases | 1 | 2007 | 1066 | 0.040 |
Why?
|
Glucose Clamp Technique | 1 | 2018 | 266 | 0.040 |
Why?
|
Receptors, LHRH | 2 | 2009 | 160 | 0.040 |
Why?
|
Mullerian Ducts | 1 | 2019 | 198 | 0.040 |
Why?
|
Ethinyl Estradiol | 1 | 2018 | 116 | 0.040 |
Why?
|
Patient Compliance | 4 | 2010 | 2684 | 0.040 |
Why?
|
Philadelphia | 1 | 2018 | 267 | 0.040 |
Why?
|
Doxorubicin | 4 | 2006 | 2234 | 0.040 |
Why?
|
Psychopharmacology | 1 | 2019 | 143 | 0.040 |
Why?
|
Histocompatibility Testing | 1 | 2019 | 741 | 0.040 |
Why?
|
Streptococcus pneumoniae | 1 | 2003 | 714 | 0.040 |
Why?
|
Comprehensive Health Care | 1 | 1998 | 127 | 0.040 |
Why?
|
Clindamycin | 1 | 2018 | 139 | 0.040 |
Why?
|
Mice | 6 | 2022 | 81201 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2021 | 15297 | 0.040 |
Why?
|
Anastomosis, Surgical | 1 | 2021 | 987 | 0.040 |
Why?
|
Carbohydrate Metabolism | 1 | 2018 | 265 | 0.040 |
Why?
|
Ischemic Attack, Transient | 1 | 2003 | 935 | 0.040 |
Why?
|
Schizophrenic Psychology | 2 | 2002 | 1678 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2009 | 250 | 0.040 |
Why?
|
Genotype | 4 | 2019 | 12952 | 0.040 |
Why?
|
Administration, Topical | 1 | 2019 | 690 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1107 | 0.040 |
Why?
|
Collagen | 1 | 2005 | 2688 | 0.040 |
Why?
|
Internal-External Control | 1 | 1999 | 363 | 0.040 |
Why?
|
Commerce | 1 | 2002 | 592 | 0.040 |
Why?
|
Creatinine | 1 | 2022 | 1919 | 0.040 |
Why?
|
Clozapine | 1 | 2000 | 498 | 0.040 |
Why?
|
Colitis, Ulcerative | 1 | 2009 | 1911 | 0.040 |
Why?
|
Reoperation | 2 | 2021 | 4201 | 0.040 |
Why?
|
Anti-Retroviral Agents | 1 | 2006 | 1714 | 0.040 |
Why?
|
Down-Regulation | 2 | 2015 | 3001 | 0.040 |
Why?
|
Calcium-Binding Proteins | 2 | 2012 | 1081 | 0.040 |
Why?
|
Leptin | 2 | 2018 | 1600 | 0.040 |
Why?
|
Genetic Markers | 3 | 2016 | 2634 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2019 | 936 | 0.040 |
Why?
|
Venous Thromboembolism | 1 | 2009 | 1671 | 0.030 |
Why?
|
Europe | 2 | 2020 | 3338 | 0.030 |
Why?
|
Cell Line, Tumor | 4 | 2017 | 16690 | 0.030 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 1997 | 245 | 0.030 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 1999 | 236 | 0.030 |
Why?
|
Microvessels | 1 | 2020 | 544 | 0.030 |
Why?
|
Vitamin B Complex | 1 | 2018 | 288 | 0.030 |
Why?
|
Subcellular Fractions | 1 | 2017 | 547 | 0.030 |
Why?
|
Asia | 1 | 2017 | 609 | 0.030 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 935 | 0.030 |
Why?
|
Creatine Kinase, MB Form | 1 | 2016 | 214 | 0.030 |
Why?
|
Drug Combinations | 2 | 2013 | 1958 | 0.030 |
Why?
|
Caloric Restriction | 1 | 2018 | 302 | 0.030 |
Why?
|
Gastric Emptying | 1 | 2018 | 233 | 0.030 |
Why?
|
Antineoplastic Agents | 3 | 2010 | 13693 | 0.030 |
Why?
|
Universal Precautions | 1 | 2015 | 34 | 0.030 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2013 | 1953 | 0.030 |
Why?
|
Psychometrics | 2 | 2010 | 3003 | 0.030 |
Why?
|
Elastic Tissue | 1 | 2015 | 65 | 0.030 |
Why?
|
Drive | 1 | 2015 | 35 | 0.030 |
Why?
|
Suction | 1 | 2016 | 267 | 0.030 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2017 | 358 | 0.030 |
Why?
|
Drug Repositioning | 1 | 2017 | 230 | 0.030 |
Why?
|
Immunoassay | 2 | 2011 | 752 | 0.030 |
Why?
|
Upper Extremity | 1 | 2020 | 648 | 0.030 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2018 | 546 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2069 | 0.030 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2009 | 360 | 0.030 |
Why?
|
Basal Metabolism | 1 | 2016 | 168 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2024 | 2016 | 0.030 |
Why?
|
Cost-Benefit Analysis | 2 | 2020 | 5388 | 0.030 |
Why?
|
Feces | 1 | 2021 | 1401 | 0.030 |
Why?
|
Exercise | 2 | 2013 | 5615 | 0.030 |
Why?
|
Cognition | 2 | 2022 | 6770 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 551 | 0.030 |
Why?
|
Program Evaluation | 2 | 2019 | 2488 | 0.030 |
Why?
|
Copper | 1 | 2017 | 366 | 0.030 |
Why?
|
Methicillin Resistance | 1 | 2015 | 198 | 0.030 |
Why?
|
Infant | 6 | 2023 | 35134 | 0.030 |
Why?
|
Placenta | 1 | 2024 | 1699 | 0.030 |
Why?
|
Nuclear Family | 1 | 1996 | 318 | 0.030 |
Why?
|
Hydrocortisone | 2 | 2015 | 1826 | 0.030 |
Why?
|
Antidepressive Agents | 2 | 2019 | 2838 | 0.030 |
Why?
|
Adipogenesis | 1 | 2017 | 359 | 0.030 |
Why?
|
Intensive Care Units | 2 | 2020 | 3680 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 2 | 2009 | 850 | 0.030 |
Why?
|
Membranes, Artificial | 1 | 2016 | 378 | 0.030 |
Why?
|
Gonads | 1 | 2014 | 109 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2019 | 1200 | 0.030 |
Why?
|
Myocardial Ischemia | 2 | 2017 | 2148 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 2015 | 520 | 0.030 |
Why?
|
Hospitals, University | 1 | 2016 | 570 | 0.030 |
Why?
|
Databases, Factual | 2 | 2020 | 7730 | 0.030 |
Why?
|
Focus Groups | 1 | 1998 | 1321 | 0.030 |
Why?
|
Deltaretrovirus Antibodies | 2 | 1991 | 9 | 0.030 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2014 | 187 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2017 | 973 | 0.030 |
Why?
|
Specialization | 1 | 1998 | 776 | 0.030 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 1999 | 518 | 0.030 |
Why?
|
Terminology as Topic | 2 | 2011 | 1547 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1070 | 0.030 |
Why?
|
Social Class | 1 | 2002 | 1997 | 0.030 |
Why?
|
Child, Preschool | 6 | 2021 | 41005 | 0.030 |
Why?
|
Anthropometry | 2 | 2010 | 1350 | 0.030 |
Why?
|
Tonometry, Ocular | 1 | 2014 | 237 | 0.030 |
Why?
|
Tablets | 1 | 2013 | 145 | 0.030 |
Why?
|
Chemical Phenomena | 1 | 2013 | 518 | 0.030 |
Why?
|
Capsules | 1 | 2013 | 196 | 0.030 |
Why?
|
Exfoliation Syndrome | 1 | 2014 | 110 | 0.030 |
Why?
|
Testis | 2 | 2009 | 804 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 956 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2023 | 2727 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2110 | 0.030 |
Why?
|
Osteopontin | 2 | 2004 | 294 | 0.030 |
Why?
|
Hospitals | 2 | 2020 | 3954 | 0.030 |
Why?
|
Australia | 1 | 2015 | 1167 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2020 | 1881 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 1613 | 0.030 |
Why?
|
Hemophilia A | 2 | 1995 | 351 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1888 | 0.030 |
Why?
|
Porosity | 1 | 2013 | 362 | 0.030 |
Why?
|
Rupture | 1 | 2013 | 433 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2006 | 648 | 0.030 |
Why?
|
Models, Animal | 1 | 2019 | 2173 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2014 | 793 | 0.030 |
Why?
|
Nose | 1 | 2015 | 509 | 0.030 |
Why?
|
Visual Field Tests | 1 | 2014 | 383 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 2014 | 486 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2019 | 2007 | 0.030 |
Why?
|
Guillain-Barre Syndrome | 1 | 2013 | 120 | 0.030 |
Why?
|
Diarrhea | 2 | 2013 | 1348 | 0.020 |
Why?
|
Diet | 2 | 2007 | 7937 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2022 | 2569 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2019 | 2765 | 0.020 |
Why?
|
Underachievement | 1 | 1991 | 15 | 0.020 |
Why?
|
Thinness | 1 | 2015 | 480 | 0.020 |
Why?
|
Practice Guidelines as Topic | 3 | 2014 | 7282 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2011 | 11366 | 0.020 |
Why?
|
Gastric Bypass | 1 | 2020 | 812 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2016 | 838 | 0.020 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2014 | 520 | 0.020 |
Why?
|
Spleen | 1 | 2017 | 2362 | 0.020 |
Why?
|
Quadriplegia | 1 | 2013 | 223 | 0.020 |
Why?
|
Bipolar Disorder | 2 | 2000 | 5027 | 0.020 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2015 | 687 | 0.020 |
Why?
|
Spinal Dysraphism | 1 | 2013 | 161 | 0.020 |
Why?
|
Blood Coagulation Factors | 1 | 1993 | 355 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 976 | 0.020 |
Why?
|
Weight-Bearing | 1 | 2013 | 515 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 21833 | 0.020 |
Why?
|
Autopsy | 1 | 2014 | 1020 | 0.020 |
Why?
|
Length of Stay | 2 | 2016 | 6311 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 2015 | 853 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2011 | 588 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1643 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2004 | 3020 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4189 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 3 | 1998 | 780 | 0.020 |
Why?
|
Women's Health | 1 | 2020 | 2034 | 0.020 |
Why?
|
Wechsler Scales | 1 | 1991 | 260 | 0.020 |
Why?
|
Ankle Brachial Index | 1 | 2011 | 154 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2004 | 3841 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3480 | 0.020 |
Why?
|
Nausea | 1 | 2013 | 674 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2017 | 1131 | 0.020 |
Why?
|
DAX-1 Orphan Nuclear Receptor | 1 | 2009 | 29 | 0.020 |
Why?
|
Sex Distribution | 1 | 2015 | 2297 | 0.020 |
Why?
|
Triiodothyronine | 1 | 2012 | 494 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2703 | 0.020 |
Why?
|
Contrast Media | 2 | 2014 | 5300 | 0.020 |
Why?
|
Recovery of Function | 1 | 2020 | 2926 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3590 | 0.020 |
Why?
|
Income | 1 | 2019 | 1913 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 977 | 0.020 |
Why?
|
Adipocytes | 1 | 2017 | 1185 | 0.020 |
Why?
|
Preoperative Care | 1 | 2019 | 2251 | 0.020 |
Why?
|
Outpatients | 1 | 2018 | 1487 | 0.020 |
Why?
|
Medicine | 1 | 1998 | 946 | 0.020 |
Why?
|
Sexual Partners | 2 | 1991 | 729 | 0.020 |
Why?
|
American Heart Association | 1 | 2014 | 1057 | 0.020 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1993 | 547 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1879 | 0.020 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2012 | 341 | 0.020 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2020 | 1537 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3279 | 0.020 |
Why?
|
Equipment Contamination | 1 | 2010 | 185 | 0.020 |
Why?
|
Palliative Care | 1 | 2004 | 3493 | 0.020 |
Why?
|
Cost of Illness | 1 | 2019 | 1860 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4851 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2021 | 2624 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2023 | 25628 | 0.020 |
Why?
|
Alleles | 2 | 2007 | 6933 | 0.020 |
Why?
|
Seizures | 1 | 2021 | 2859 | 0.020 |
Why?
|
New England | 1 | 2012 | 1022 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4328 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1771 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2716 | 0.020 |
Why?
|
Speech Recognition Software | 1 | 2009 | 72 | 0.020 |
Why?
|
Hemorrhage | 1 | 2021 | 3461 | 0.020 |
Why?
|
Fathers | 1 | 2011 | 358 | 0.020 |
Why?
|
Sickness Impact Profile | 1 | 2010 | 302 | 0.020 |
Why?
|
Phototherapy | 1 | 2011 | 377 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2015 | 1205 | 0.020 |
Why?
|
Aortography | 1 | 2010 | 437 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6755 | 0.020 |
Why?
|
Informed Consent | 1 | 2015 | 995 | 0.020 |
Why?
|
Cold Temperature | 1 | 2012 | 772 | 0.020 |
Why?
|
Policy | 1 | 2012 | 508 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1184 | 0.020 |
Why?
|
Limb Salvage | 1 | 2011 | 433 | 0.020 |
Why?
|
Cerebral Palsy | 1 | 2013 | 459 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2010 | 408 | 0.020 |
Why?
|
Biological Availability | 1 | 2009 | 397 | 0.020 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2026 | 0.020 |
Why?
|
Vascular Patency | 1 | 2011 | 887 | 0.020 |
Why?
|
Dermatologic Agents | 1 | 2011 | 278 | 0.020 |
Why?
|
Karyotyping | 1 | 2010 | 1243 | 0.020 |
Why?
|
Ketoconazole | 1 | 2007 | 95 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2009 | 648 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2016 | 2480 | 0.020 |
Why?
|
E-Selectin | 1 | 2010 | 579 | 0.020 |
Why?
|
Psychological Tests | 1 | 2010 | 651 | 0.020 |
Why?
|
Guanine | 1 | 2008 | 274 | 0.020 |
Why?
|
Retreatment | 1 | 2009 | 610 | 0.020 |
Why?
|
Glutamates | 1 | 2008 | 398 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2016 | 1736 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 4 | 2019 | 17446 | 0.020 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2008 | 126 | 0.020 |
Why?
|
Body Constitution | 1 | 2007 | 278 | 0.020 |
Why?
|
Remission, Spontaneous | 1 | 2007 | 382 | 0.020 |
Why?
|
Apolipoprotein E2 | 1 | 2007 | 127 | 0.020 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2018 | 1462 | 0.020 |
Why?
|
Skin | 1 | 2020 | 4372 | 0.020 |
Why?
|
Puberty, Delayed | 1 | 2007 | 115 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2010 | 1472 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2011 | 1094 | 0.020 |
Why?
|
Smoking Cessation | 1 | 1998 | 2071 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2009 | 601 | 0.020 |
Why?
|
Kallmann Syndrome | 1 | 2007 | 140 | 0.020 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2018 | 1458 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2015 | 1928 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9735 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3086 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2012 | 2242 | 0.020 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2010 | 567 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 5895 | 0.020 |
Why?
|
Dinoprostone | 1 | 2009 | 601 | 0.020 |
Why?
|
Hepatitis A Vaccines | 1 | 2005 | 29 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2019 | 2988 | 0.020 |
Why?
|
Drug Utilization | 1 | 2012 | 1183 | 0.020 |
Why?
|
Health Resources | 1 | 2012 | 911 | 0.020 |
Why?
|
Physicians, Family | 1 | 2008 | 345 | 0.020 |
Why?
|
Fatigue | 1 | 2013 | 1531 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2007 | 8861 | 0.020 |
Why?
|
Urethra | 1 | 2008 | 408 | 0.020 |
Why?
|
Homeostasis | 1 | 2017 | 3339 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2010 | 624 | 0.020 |
Why?
|
Personality Inventory | 2 | 1999 | 1030 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2013 | 2924 | 0.020 |
Why?
|
Carotid Artery, Common | 1 | 2006 | 183 | 0.020 |
Why?
|
Chromosome Mapping | 3 | 1998 | 4740 | 0.020 |
Why?
|
Nerve Tissue Proteins | 2 | 2009 | 4463 | 0.020 |
Why?
|
Hormones | 1 | 2009 | 889 | 0.020 |
Why?
|
Exercise Test | 1 | 2013 | 2073 | 0.020 |
Why?
|
Public Health | 1 | 1998 | 2602 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2166 | 0.020 |
Why?
|
Antigens, CD | 2 | 1993 | 4026 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2010 | 1880 | 0.020 |
Why?
|
Calcitriol | 1 | 2006 | 297 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2453 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2010 | 2029 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2006 | 553 | 0.020 |
Why?
|
Behavior Control | 1 | 2004 | 45 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2010 | 1877 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3707 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 2566 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 5984 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2015 | 2897 | 0.020 |
Why?
|
Organ Size | 1 | 2009 | 2251 | 0.020 |
Why?
|
Steroids | 1 | 2009 | 930 | 0.020 |
Why?
|
Hypertriglyceridemia | 1 | 2007 | 293 | 0.010 |
Why?
|
Poverty | 1 | 2016 | 2660 | 0.010 |
Why?
|
World Health Organization | 1 | 2010 | 1318 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1993 | 6366 | 0.010 |
Why?
|
Immunization | 1 | 2008 | 1256 | 0.010 |
Why?
|
Carotid Arteries | 1 | 2008 | 950 | 0.010 |
Why?
|
Cystadenocarcinoma, Papillary | 1 | 2003 | 59 | 0.010 |
Why?
|
Complementary Therapies | 1 | 2008 | 486 | 0.010 |
Why?
|
Pelvis | 1 | 2008 | 730 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2649 | 0.010 |
Why?
|
Myocardium | 1 | 2016 | 4772 | 0.010 |
Why?
|
Oxidoreductases Acting on CH-NH Group Donors | 1 | 2003 | 63 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 5974 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2010 | 5172 | 0.010 |
Why?
|
Prostatectomy | 1 | 2012 | 1890 | 0.010 |
Why?
|
Psychology | 1 | 2005 | 356 | 0.010 |
Why?
|
Pyridoxal Phosphate | 1 | 2003 | 127 | 0.010 |
Why?
|
Signal Transduction | 1 | 2006 | 23404 | 0.010 |
Why?
|
Heart Atria | 1 | 2009 | 1356 | 0.010 |
Why?
|
Rectum | 1 | 2008 | 904 | 0.010 |
Why?
|
Apolipoprotein E4 | 1 | 2007 | 668 | 0.010 |
Why?
|
Drug Resistance, Bacterial | 1 | 2010 | 1035 | 0.010 |
Why?
|
Family Characteristics | 1 | 2008 | 1000 | 0.010 |
Why?
|
Serotyping | 1 | 2003 | 338 | 0.010 |
Why?
|
Vagina | 1 | 2008 | 825 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2012 | 9955 | 0.010 |
Why?
|
Control Groups | 1 | 2002 | 105 | 0.010 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2003 | 305 | 0.010 |
Why?
|
Asthma | 1 | 2001 | 6010 | 0.010 |
Why?
|
Blood Pressure | 2 | 2008 | 8551 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2015 | 3188 | 0.010 |
Why?
|
Gene Dosage | 1 | 2007 | 1252 | 0.010 |
Why?
|
Urban Population | 1 | 2010 | 2022 | 0.010 |
Why?
|
Government Programs | 1 | 2004 | 275 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1364 | 0.010 |
Why?
|
Primary Health Care | 1 | 1998 | 4557 | 0.010 |
Why?
|
Health Status | 2 | 2010 | 4034 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2001 | 15520 | 0.010 |
Why?
|
Femur Neck | 1 | 2003 | 309 | 0.010 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2003 | 284 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3252 | 0.010 |
Why?
|
Sperm Count | 1 | 2002 | 216 | 0.010 |
Why?
|
Cryptorchidism | 1 | 2002 | 125 | 0.010 |
Why?
|
Curriculum | 1 | 2015 | 3605 | 0.010 |
Why?
|
Decision Making | 1 | 2015 | 3888 | 0.010 |
Why?
|
Vaccines, Combined | 1 | 2001 | 69 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18034 | 0.010 |
Why?
|
Software | 1 | 1996 | 4441 | 0.010 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2004 | 629 | 0.010 |
Why?
|
Primary Prevention | 1 | 2009 | 1167 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2015 | 3229 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2006 | 973 | 0.010 |
Why?
|
Affect | 1 | 2009 | 1475 | 0.010 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2004 | 548 | 0.010 |
Why?
|
Age of Onset | 1 | 2008 | 3270 | 0.010 |
Why?
|
Sodium | 1 | 2006 | 1622 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3508 | 0.010 |
Why?
|
Mothers | 1 | 2011 | 2165 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2004 | 2050 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2282 | 0.010 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2000 | 108 | 0.010 |
Why?
|
Heterozygote | 1 | 2007 | 2804 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2010 | 2419 | 0.010 |
Why?
|
Genetic Variation | 1 | 1996 | 6542 | 0.010 |
Why?
|
Family | 1 | 1991 | 3147 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 2003 | 867 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 2003 | 527 | 0.010 |
Why?
|
Antibodies | 1 | 2008 | 2460 | 0.010 |
Why?
|
Serum Albumin | 1 | 2003 | 675 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2007 | 1222 | 0.010 |
Why?
|
Motivation | 1 | 2010 | 1971 | 0.010 |
Why?
|
Sexual Behavior | 1 | 2009 | 2055 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2010 | 2760 | 0.010 |
Why?
|
Immunization, Secondary | 1 | 2001 | 340 | 0.010 |
Why?
|
Cytoplasm | 1 | 2004 | 1536 | 0.010 |
Why?
|
Energy Intake | 1 | 2007 | 2148 | 0.010 |
Why?
|
Assertiveness | 1 | 1999 | 18 | 0.010 |
Why?
|
Cross-Cultural Comparison | 1 | 2002 | 651 | 0.010 |
Why?
|
Health Maintenance Organizations | 1 | 2002 | 642 | 0.010 |
Why?
|
Florida | 2 | 1991 | 435 | 0.010 |
Why?
|
Health Care Costs | 1 | 2012 | 3208 | 0.010 |
Why?
|
Leukocytes | 1 | 2007 | 2045 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 2002 | 676 | 0.010 |
Why?
|
Safety | 1 | 2003 | 1186 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2008 | 2494 | 0.010 |
Why?
|
Critical Illness | 1 | 2011 | 2670 | 0.010 |
Why?
|
Ambulatory Care | 2 | 1999 | 2708 | 0.010 |
Why?
|
Patient Dropouts | 1 | 2000 | 420 | 0.010 |
Why?
|
Medication Adherence | 1 | 2009 | 2063 | 0.010 |
Why?
|
Occipital Lobe | 1 | 1999 | 379 | 0.010 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 1998 | 374 | 0.010 |
Why?
|
Canada | 1 | 2002 | 2065 | 0.010 |
Why?
|
Models, Biological | 1 | 2014 | 9584 | 0.010 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 1998 | 380 | 0.010 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 1998 | 367 | 0.010 |
Why?
|
Up-Regulation | 1 | 2006 | 4222 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2006 | 3505 | 0.010 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 1998 | 373 | 0.010 |
Why?
|
DNA, Viral | 1 | 2003 | 2227 | 0.010 |
Why?
|
Echocardiography | 1 | 2009 | 5099 | 0.010 |
Why?
|
Limbic System | 1 | 1999 | 426 | 0.010 |
Why?
|
Marijuana Abuse | 1 | 2000 | 403 | 0.010 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 1998 | 460 | 0.010 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 1998 | 535 | 0.010 |
Why?
|
Lod Score | 1 | 1997 | 614 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1998 | 798 | 0.010 |
Why?
|
Benzodiazepines | 1 | 2002 | 1101 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2002 | 2377 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3921 | 0.010 |
Why?
|
MicroRNAs | 1 | 2011 | 3751 | 0.010 |
Why?
|
Ultrasonography | 1 | 2008 | 5984 | 0.010 |
Why?
|
Phosphorylation | 1 | 2006 | 8436 | 0.010 |
Why?
|
Epilepsy | 1 | 1991 | 3310 | 0.010 |
Why?
|
Genome, Human | 2 | 1998 | 4420 | 0.010 |
Why?
|
Blood Component Transfusion | 1 | 1995 | 143 | 0.010 |
Why?
|
Atrophy | 1 | 1999 | 1584 | 0.010 |
Why?
|
Parietal Lobe | 1 | 1999 | 838 | 0.010 |
Why?
|
Mutation | 2 | 2009 | 29786 | 0.010 |
Why?
|
Confidentiality | 1 | 1998 | 612 | 0.010 |
Why?
|
Cause of Death | 1 | 2004 | 3582 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2005 | 2987 | 0.010 |
Why?
|
Demography | 1 | 1997 | 1655 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2004 | 3690 | 0.010 |
Why?
|
Frontal Lobe | 1 | 1998 | 1406 | 0.010 |
Why?
|
Functional Laterality | 1 | 1998 | 2290 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2004 | 2375 | 0.010 |
Why?
|
Radioimmunoprecipitation Assay | 1 | 1991 | 16 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 1997 | 2887 | 0.010 |
Why?
|
Psychosocial Deprivation | 1 | 1991 | 99 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 1998 | 1901 | 0.010 |
Why?
|
West Indies | 1 | 1989 | 34 | 0.010 |
Why?
|
Apoptosis | 1 | 2006 | 9724 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2008 | 5321 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2000 | 6036 | 0.010 |
Why?
|
San Francisco | 1 | 1989 | 159 | 0.010 |
Why?
|
Los Angeles | 1 | 1989 | 238 | 0.010 |
Why?
|
Homosexuality | 1 | 1989 | 262 | 0.010 |
Why?
|
Prefrontal Cortex | 1 | 1999 | 2147 | 0.010 |
Why?
|
Memory | 1 | 1998 | 2174 | 0.010 |
Why?
|
Health Behavior | 1 | 2000 | 2635 | 0.010 |
Why?
|
Attention | 1 | 1998 | 2397 | 0.000 |
Why?
|
Homosexuality, Male | 1 | 1995 | 1240 | 0.000 |
Why?
|
Immunoenzyme Techniques | 1 | 1991 | 1799 | 0.000 |
Why?
|
New York City | 1 | 1989 | 710 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2003 | 19233 | 0.000 |
Why?
|
Parent-Child Relations | 1 | 1991 | 747 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1993 | 2373 | 0.000 |
Why?
|
Blotting, Western | 1 | 1991 | 5181 | 0.000 |
Why?
|
Brain | 1 | 1999 | 26388 | 0.000 |
Why?
|